Search clinical trials for: Ublituximab TGR-1202 ibrutinib
Total 68 results
-
Weill Medical College of Cornell UniversityTG Therapeutics, Inc.TerminatedChronic Lymphocytic Leukemia | CLL/SLL | CLL ProgressionUnited States
-
TG Therapeutics, Inc.TerminatedChronic Lymphocytic LeukemiaUnited States, Poland, Italy, United Kingdom
-
TG Therapeutics, Inc.TerminatedStudy to Assess Umbralisib Plus Ublituximab in Participants With Treatment Naïve Follicular LymphomaFollicular Lymphoma | Small Lymphocytic LymphomaUnited States
-
TG Therapeutics, Inc.TerminatedChronic Lymphocytic Leukemia | Non Hodgkin LymphomaUnited States
-
TG Therapeutics, Inc.CompletedNon-Hodgkin's Lymphoma | Chronic Lymphocytic LeukemiaUnited States
-
TG Therapeutics, Inc.Memorial Sloan Kettering Cancer CenterCompletedChronic Lymphocytic Leukemia | Richter SyndromeUnited States
-
TG Therapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Non Hodgkin LymphomaAustralia, Poland
-
TG Therapeutics, Inc.Terminated
-
University of Alabama at BirminghamTerminated
-
TG Therapeutics, Inc.TerminatedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
TG Therapeutics, Inc.CompletedChronic Lymphocytic LeukemiaUnited States, Israel
-
University of NebraskaNational Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
TG Therapeutics, Inc.CompletedMantle Cell Lymphoma | Chronic Lymphocytic LeukemiaUnited States
-
TG Therapeutics, Inc.TerminatedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic LymphomaUnited States, Poland, Australia, Italy, United Kingdom, Israel, Korea, Republic of, Slovakia, Spain
-
TG Therapeutics, Inc.SCRI Development Innovations, LLCCompletedHodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Peripheral T-Cell LymphomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteTG Therapeutics, Inc.TerminatedChronic Lymphocytic LeukemiaUnited States
-
Dana-Farber Cancer InstituteTG Therapeutics, Inc.; The Leukemia and Lymphoma Society; Blood Cancer Research...Active, not recruitingMantle Cell Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
TG Therapeutics, Inc.CompletedWaldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Non Follicular Indolent Non-Hodgkin LymphomaUnited States
-
Columbia UniversityTG Therapeutics, Inc.Terminated
-
TG Therapeutics, Inc.CompletedChronic Lymphocytic LeukemiaUnited States, Israel, Italy, Poland, Russian Federation, Spain, United Kingdom
-
TG Therapeutics, Inc.RecruitingRelapsing Multiple SclerosisUnited States
-
Columbia UniversityTerminatedHodgkin Disease | Lymphoma, Non-hodgkinUnited States
-
TG Therapeutics, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
TG Therapeutics, Inc.James P. Wilmot Cancer CenterTerminatedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnRecurrent Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
TG Therapeutics, Inc.Completed
-
TG Therapeutics, Inc.CompletedMultiple SclerosisUnited States
-
Vanderbilt-Ingram Cancer CenterActive, not recruitingPolycythemia Vera | MyelofibrosisUnited States
-
TG Therapeutics, Inc.Active, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | DLBCL | CLL | MCL | Indolent Lymphoma | Richter's Transformation | SLL | Mediastinal Large B-cell Lymphoma | Aggressive LymphomaUnited States
-
Yazeed SawalhaWithdrawnRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Refractory Grade 1 Follicular... and other conditions
-
Massachusetts General HospitalTG TherapeuticsActive, not recruitingLymphoma | Follicular Lymphoma | Marginal Zone Lymphoma | Follicular Lymphoma, Grade 1 | Follicular Lymphoma Grade IIIa | Marginal Zone B Cell Lymphoma | Follicular Lymphoma Grade 2United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMantle Cell LymphomaUnited States
-
University of ChicagoActive, not recruitingCLL | B-cell Non Hodgkin LymphomaUnited States
-
TG Therapeutics, Inc.Active, not recruitingRelapsing Multiple Sclerosis (RMS)United States, Belarus, Croatia, Georgia, Poland, Russian Federation, Serbia, Ukraine
-
TG Therapeutics, Inc.CompletedHodgkin's LymphomaUnited States
-
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.MediBeaconCompletedKidney Diseases | Kidney Injury | Kidney FailureChina
-
CelgeneCompletedLeukemia, Lymphocytic, Chronic, B-CellSpain, United States, Italy, Germany, Austria
-
MediBeaconRecruitingKidney Diseases | Kidney Injury | Kidney FailureUnited States
-
MediBeaconCompleted
-
TG Therapeutics, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
TG Therapeutics, Inc.TerminatedMantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Waldenstrom's Macroglobulinemia | Non-Hodgkins Lymphoma | Small Lymphocytic Lymphoma | B-cell LymphomasUnited States
-
University of WashingtonTG Therapeutics, Inc.TerminatedHodgkin's LymphomaUnited States
-
TG Therapeutics, Inc.CompletedRelapsing Multiple Sclerosis (RMS)United States
-
TG Therapeutics, Inc.CompletedRelapsing Multiple Sclerosis (RMS)United States
-
CelgeneCompletedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-HodgkinUnited States
-
TCRCure Biopharma Ltd.Fudan UniversityRecruiting
-
Mie UniversityFiverings Co., Ltd.; Shionogi; Takara Bio Inc.; Statcom Co. Ltd.Completed
-
Trius Therapeutics LLCCompleted
-
TG Therapeutics, Inc.SCRI Development Innovations, LLCCompletedGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Gastrointestinal Stromal Tumor (GIST)United States
-
Alice BertainaCalifornia Institute for Regenerative Medicine (CIRM)RecruitingCKD Stage 4 | Cystinosis | FSGS | SLE Nephritis | SIODUnited States